WEDNESDAY, June 30, 2021 (HealthDay News) — Because they’re often given drugs that suppress their immune systems, people battling a blood cancer known as multiple myeloma have varying responses to the COVID-19 vaccine, new research shows. Some patients had no evidence at all of COVID-fighting antibody production after getting twoContinue Reading

WEDNESDAY, June 30, 2021 (HealthDay News) — Despite being particularly susceptible to severe COVID-19, many U.S. teen and young adult cancer survivors are wary of vaccination, a new study finds. Cancer survivors often have weakened immune systems and are more likely to develop severe respiratory infections. That puts them atContinue Reading

TUESDAY, June 29, 2021 (HealthDay News) — Black American military veterans with aggressive prostate cancer who would benefit from surgery or radiation are less likely to get those treatments than men of other races, despite equal access to health care, a new study finds. “Despite great strides in prostate cancerContinue Reading

MONDAY, June 28, 2021 (HealthDay News) — You decide to take a popular colon cancer screening test that can be performed at home, and it comes back positive. A follow-up colonoscopy is scheduled, but then you suddenly receive a large and unexpected medical bill. That’s what happened to a MissouriContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as aContinue Reading